Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Faculty Disclosures

Matthew J. Loscalzo, LCSW – Consultant AstraZeneca, PrecisCA
City of Hope National Medical Center

Shirley Mertz, MA, JD – Nothing to disclose
Metastatic Breast Cancer Network

Joanne Mortimer, MD, FACP – honorariums from Puma Biotechnology, Glaxo Smith Kline Pharmaceuticals (GSK), and Pfizer 
City of Hope Comprehensive Cancer Center        

Colette Salm-Schmid, MD, FACS—Nothing to disclose    
Prevea/HSHS St. Vincent’s Regional Cancer Program

Sally Werner, RN, BSN, MHA – Nothing to disclose
Cancer Support Community 

Program Committee Disclosures

Wendy Austin, RN, MS, AOCN, COA, NEA-BC, FACHE – Nothing to disclose 
Association of Cancer Executives 

Susan Brown, MS, RN – Nothing to disclose
Susan G. Komen 

Connie Bura – Nothing to disclose
American College of Surgeons

Lauren Chatalian, LMSW – Nothing to disclose
CancerCare

Sue Friedman, DVM – Nothing to disclose
Facing Our Risk of Cancer Empowered 

Janine Guglielmino – Nothing to disclose
Living Beyond Breast Cancer

Scott Kurtzman, MD, FACS – Nothing to disclose
Waterbury Hospital

Stacy Lewis – Nothing to disclose
Young Survival Coalition

Ginny Mason, RN – Nothing to disclose
Inflammatory Breast Cancer Research Foundation 

Linda Moy, MD – NYU receives Siemens research grant for research on breast MRI, honorarium for iCad for discussion market trends, stock options at Lunit for discussion US market trends 
NYU Langone Health

Tara Schapmire, PhD, MSSW, OSW-C, FNAP, FAOSW – Nothing to disclose
Association of Oncology Work

Lauren Teras, PhD – Nothing to disclose
American Cancer Society

Katharine Yao, MD, FACS – Nothing to disclose
NorthShore University HealthSystem